Featuring numerous voices and perspectives of people who have helped advance nephrology and kidney health, these articles include interviews with physicians, patients, scientists, specialists, advanced practice providers, and others in the field.
Recognizing Those Who Have Changed Nephrology: Michelle Winn, MD, FASN: "Michelle was an incredible physician scientist and human being. She was the heart and soul of our podocyte community. To me, she was the perfect role model, and exemplified everything that is good in medicine and the world. I feel privileged to have counted her as a colleague, a confidante and most of all, my friend. Her passing left many of us heartbroken. To her tribute, her legacy lives on in her many groundbreaking discoveries and amazing nephrologists like Dr. Gentzon." --Susan E. Quaggin, MD, FASN, President, American Society of Nephrology Read more.
ASN Podcast: What's Next for the Affordable Care?: In this ASN Podcast, ASN Executive Vice President Tod Ibrahim and ASN Regulatory and Quality Officer David White offer insights about Capitol Hill politics related to kidney health and policy issues. They talk about the Democratic majority’s plan to increase funding for the Affordable Care Act in order to reduce the cost of insurance. They also discuss the latest news about transplant policy and the mandatory and voluntary payment models for nephrologists. Listen to the podcast.
Q&A with ASN's Policy Team on Current Advocacy During COVID-19: The Surprise Health professionals are facing a barrage of unexpected challenges when caring for patients during the COVID-19 pandemic. Addressing these challenges often requires sustained effort by policy experts, who make the case to government and regulatory agencies when urgent, sometimes unprecedented changes, must be enacted to provide the best possible care. Members of the ASN policy team have successfully advocated for a number of key changes during this crisis. Read more.
Interview with Young Scientist Uma D. Alappan: As you know, the nephrology workforce is shrinking. Not many people are interested in going into nephrology today. As someone who is very young in your career, yet with a lot of motivation and a strong interest in the field of nephrology, what would be your advice to your peers? To leaders in nephrology? Read more.
An Interview with Kerry Cooper, MD, Vice President, U.S. Medical Affairs, Renal, AstraZeneca: As a global organization, we show up as one therapeutic area—cardiovascular, renal, and metabolism or "CVRM." With our expertise over time in this space, we recognize that science has uncovered commonalities between cardiovascular, renal, and metabolic diseases and their associated complications. Yet in many cases, each condition is managed in isolation. Read more.
Interview: Dr. Michael Allon, Editor-in-Chief of the new ASN journal, Kidney360: Kidney News Online spoke with Michael Allon, MD, the inaugural Editor-in-Chief for the newest journal from the American Society of Nephrology, Kidney360. As the open access, online only journal will begin accepting manuscripts in September 2019, KNO wanted to learn more about Dr. Allon and the ideas behind the new journal. Read more.
